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ABSTRACT We studied thrombin binding to proliferating and confluent endothelial cells
derived from bovine vascular endothelium . [' 251]thrombin was incubated with nonconfluent
or confluent endothelial cells and both the total amount bound and the amount linked in a
77,000-dalton thrombin-cell complex were determined. Approximately 230,000 molecules of
thrombin bound per cell in nonconfluent cultures compared to 12,800 molecules per cell in
confluent cultures. Approximately 67,000 thrombin molecules were bound in an apparently
covalent complex, Mr = 77,000, with each cell in sparse cultures, whereas only 4,600 thrombin
molecules per cell were bound in this complex with confluent cultures. Similar studies with
[1251]thrombin and endothelial cells derived from bovine cornea revealed no difference either
in the total amount of thrombin bound or in the amount bound in the 77,000-dalton complex
using sparse or confluent cultures . When confluent vascular endothelial cultures were
wounded, additional cellular binding sites for the 77,000-dalton complex with thrombin
appeared within 24 h . A 237% increase in the amount of thrombin bound to these sites was
induced by a wound which resulted in a 20% decrease in cell number in the monolayer. There
was no significant increase in thrombin binding to other cellular sites at 24 h . These experiments
provide evidence that the first change in thrombin binding after injury is an increase in the
cellular sites involved in the 77,000-dalton complex, and suggest that thrombin binding to
endothelial cells may be important in the vascular response to injury.
The endothelium serves as an interface between blood and the
vessels in which it circulates. Previous studies have emphasized
the importance of the endothelium in preventing activation of
the coagulation system (25). The endothelium appears to be
unreactive toward clotting enzymes which have not been acti-
vated; however, at leasttwo reactions occur between thrombin,
an activated coagulation factor, and endothelial cells in tissue
culture. Thrombin stimulates prostaglandin synthesis which
results in the formation and release ofprostacyclin by umbilical
vein endothelial cells (28). Thrombin also inhibits activation of
plasminogen by endothelial cells derived from a variety of
tissues (8, 21). Although it is not mitogenic for endothelial
cells, thrombin enhances the mitogenic effect of fibroblast
growth factor (FGF) on human aortic endothelial cells (14).
This observation should be interpreted with caution, however,
because thrombin does not have this effect on bovine aortic
endothelial cells.
To date, little information has been published on the nature
ofthe interaction between thrombin and vascular endothelium.
Specific and saturable binding of thrombin to umbilical vein
endothelium has been described (1). Like the binding reaction
to platelets (26), binding to vascular endothelium is reversible,
and both native and active site-inhibited thrombin bind iden-
tically to endothelial cells. Because inhibited thrombin has no
known physiological effect (5), the significance ofthis reaction
is unclear. Moreover, excess unlabeled thrombin inhibited at
its active site blocks binding of native thrombin to platelets,
but does not prevent thrombin-induced secretion. These bind-
ing sites are specific for thrombin because neither prothrombin
or prethrombin intermediates bind to them (27).
A second type of thrombin binding to fibroblasts (2) and
endothelial cells derived from the bovine cornea (BCE) (15)
and umbilical vein (20) has been reported. Thrombin binds to
specific cellular sites with the formation ofanapparent covalent
bond. Thrombin inhibited at its active serine site does not
appear to bind covalently to these sites, however. Moreover,
urokinase (3) and trypsin (18) appear to bind covalently to the
same site.
The purpose ofthis study was to determine the nature of the
interaction between thrombin and the aortic endothelium, the
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between blood and the vessel wall. We have discovered that
covalent thrombin binding is markedly influenced by whether
or notthecellsarecontact-inhibited, and that covalent binding
sites rapidly appear on adult bovine aortic endothelial cells
(ABAE) afterinjury to confluent endothelium. We believethat
these results provideevidence of arole forthe covalent binding
sites in the vascular response to injury.
MATERIALS AND METHODS
Materials
Crystalline bovine serum albumen, Fraction V (BSA), lactoperoxidase, and
glucose oxidase (type 5) were obtained from Sigma Chemical Co. (St. Louis,
Mo.); Dulbecco's modified Eagles medium (DMEM) and calf serum were
purchased from Grand Island Biological Co. (Grand Island, N. Y.). Gentamycin
was obtained from Schering (Kenilworth, N. J.). Tissue-culture dishes were
purchased from Falcon Plastics, Inc. (Oxnard, Calif.). Carrier-free, sodium
["I]iodide was purchased from Amersham Corp. (Arlington Heights, Ill). A
molecular weight standards kit was obtained from Bio-Rad Laboratories (Rich-
mond, Calif.). Diisopropylfluorophosphate (DFP) was purchased from Aldrich
Chemical Co. (Milwaukee, Wis.).
Preparation of Thrombin and FGF
Human a thrombin was a generous gift from J. W. Fenton, If (9). The specific
activities ranged from 2,400-4,000 U/mg. Fibroblast growth factor (FGF) was
purified from bovine brain as previously described (13).
Endothelial Cell Preparation
BCE and ABAE cells were isolated as previously described (11, 12). Cells in
their second to twelfth passage were grown to confluence at 37°C in 10% COs in
DMEM containing 10% calfserum. 100 ng/ml FGF were added every otherday
to the cultures.
Iodination of Thrombin
Human thrombin (150 U) was radioiodinated at room temperature using 0.05
U lactoperoxidase, 0.01 U glucose oxidase, 0.2% S-d-glucose, 4 mCi sodium
(12'I]iodide, 0.01 M benzamidine, and buffer containing 0.2 M NaCI-0.05 M
sodium phosphate (pH 6.7) for 1 min in a total volume of0.2 ml. [1251]thrombin
was separated from free sodium ['251]iodide by gel filtration.
Preparation of Diisopropyl Fluorophosphate
(DFP)-inhibited Thrombin (DIP-Thrombin)
Thrombin, 4 mg in l ml of0.75 M NaCl, 0.05 M imidazole, 0.025 M sodium
phosphate, pH 7.50, was incubated with 0.01 M DFP for 50 min at room
temperature (^-22°C). The thrombin was then dialyzed against 250 ml of0.75 M
NaCl, 0.05 M sodium phosphate, pH 6.65, for 16 h at 4°C. (1251]thrombin was
treated similarly, except that excess DFP was removed by gel filtration.
Binding of[ "5I]Thrombin
Confluent monolayers containing 9.0 x 105-1.2 x 106 cells or nonconfluent
(sparse) 0.18-0.50 x 106 cells were grown on 35-mm culture dishes. The cells
were washed three times with DMEM supplemented with 0.5% bovine serum
albumin (BSA). To initiate binding, radiolabeled ligand was added to the cells in
1 .0 ml of the same medium. After incubation at 37°C, the cell monolayers were
washed rapidly ten times with 1-2 ml of cold phosphate-buffered saline (PBS)
containing 0.1% BSA. The washed monolayers were lysed in 0.1 ml of buffer
containing 15% glycerol, 2% SDS, 75 mM Tris-HCl (pH 6.8), 2 mM phenylmeth-
ylsulfonyl fluoride, and 2 mM EDTA. 1 mM N-ethytmaleimide and 1 .0 mM
iodoacetic acid were added to block free sulfhydryl groups (henceforth referred
to as SDS-lysis buffer). Specific binding was determined by measuring the
difference in cell-bound radioactivity in the presence and absence of a 100-fold
excess of unlabeled thrombin. The cell-bound radioactivity in the presence of an
excess amount ofunlabeled thrombin was considered to be nonspecific and was
subtracted from the results.
PAGE
We applied aliquots (0.033 ml) containing one-third of the total solubilized
cellular material to 10% polyacrylamide slab gels with 3% stacking gel, as
described by Laemmli (19). After electrophoresis at 20 mA, the slab gel was
stained with Coomassie Blue (0.1%) in 50% trichloracetic acid and subsequently
destained overnight. The gels were dried and subjected to autoradiography on
Kodak NS-2T x-ray film. The areas of the gel corresponding to the band of
radioactivity on the autoradiogram were sliced and counted in a Beckman
gamma-300 spectrometer (Beckman Instruments, Inc., Irvine, Calif.).
Calculation of thrombin binding to cells was corrected for quenching of the
gamma radioactivity by the polyacrylamide gel using [1251]Na standards.
Cell Monolayer Wounding
Confluent ABAE cultures in 35-mm dishes were washed once with fresh
DMEM supplemented with 10% calfserum. A wound running from side to side
(3-4 mm in width) was made in the center of the monolayer with a rubber
policeman. Cultures were then washed three times to remove cell aggregates
made by wounding. Cultures were examined by phase-contrast microscopy to
ensure that all cells released from the culture dish had been removed. Medium
supplemented with 10% calf serum and FGF, 100 ng/ml, was then added to the
cultures. After 24 h, the cells were washed three times with DMEM-0.5% BSA
and ['251]thrombin binding was measured. Triplicates of wounded and control
confluent cultures were trypsinized and cell number was determined ina Coulter
counter (Coulter Electronics Inc., Hialeah, Fla.).
RESULTS
Measurement of Binding of [ ' 25I]Thrombin to
ABAE Cells
Confluent and nonconfluent ABAE cells were incubated
with f1251]thrombin, then washed and solubilized, and the
radioactivity associated with the cells measured by gamma
scintillation counting. As shownin Fig. 1, [1251]thrombin bound
to both confluent and nonconfluent cells. In nonconfluent
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FIGURE 1 Binding of ['251]thrombin to ABAE cells. Confluent
(1,179,000 cells/plate) or nonconfluent (182,550 cells/plate) were
incubated with [1251]thrombin (10.0 x 108 Cpm/U) for 30 min at
37°C in DMEM. The incubation was terminated by rapidlywashing
the plates; then the cells were solubilized in SDS buffer (see Mate-
rials and Methods) . The amount of [' 251] thrombin bound to the
cells was determined in a gamma scintillation counter. Specific
binding represented [1211] thrombin associated with the cells which
could be blocked by simultaneous incubation of a 100-fold excess
of unlabeled thrombin . This represented <_10%of the total amount
bound. 0--0, nonconfluent. o--0, confluent.
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671cultures (1.8 x 105 cells/35-mm dish), thrombin binding was
linear up to a concentration of~0.5 [Lg/ml . The amount bound
to the cells appeared to reach a plateau at 4 fag/ml of added
enzyme . Considerably less ["'I]thrombin bound to confluent
ABAE cells (1.2 x 106 cells/35-mm dish) . Saturation was
reached at -2 pg/ml of added thrombin . Approximately
230,000 molecules of thrombin bound per cell in the noncon-
fluent culture and 12,800 molecules/cell in the confluent cul-
ture .
Nonconfluent cells were incubated with [1251]thrombin for
varying intervals, and the amount bound was determined . As
shown in Fig. 2, binding could be detected after only 1 min of
incubation. Thrombin binding was relatively rapid for the
initial 30-60 min, then continued at a slower rate for the next
2 .5 h . In previous studies of thrombin binding to BCE cells, we
showed that the slower rate of thrombin binding is largely the
result of cellular internalization of the thrombin-binding site
complex (23) . It is possible that the same process occurs with
the ABAE cells . When a time-course of thrombin binding to
confluent ABAE cells was carried out, results similar to Fig . 2
were obtained (data not shown) .
Thrombin Binding to a Specific Site on ABAE
Cells
Nonconfluent ABAE cells were incubated with 2.15 F1g/ml
of [1251]thrombin for 60 min, and after washing they were
solubilized in SDS and electrophoresed inSDS-10% polyacryl-
amide gels. An autoradiogram ofthe gel showed a [125I]throm-
bin-complex, Mr 77,000 daltons (Fig. 3) . Formation of
[1251]thrombin-cell complex was completely blocked by addi-
tion of a 100-fold excess of unlabeled thrombin (Fig . 3) . In
addition to the 77,000 dalton complex and free [1251]thrombin,
other radioactive bands were occasionally noted on autora-
diography . The most prominent ofthese bands were M, 45,000
and 32,000 daltons . The latter band which is smaller than
thrombin (36,500 daltons) was also noted in the presence of
excess unlabeled thrombin. Relatively more 45,000 dalton com-
plex was seen with confluent than nonconfluent cells .
Although specific binding of [1251]DIP-thrombin to ABAE
cells was observed, no 77,000-dalton complex was demonstra-
ble on the autoradiogram (Fig . 3, Lanes 4 and S) . A 40-fold
excess of unlabeled DIP-thrombin blocked both covalent and
noncovalent binding of [1251]thrombin to ABAE cells (Lane 3) .
These results indicate that although the active site of thrombin
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FIGURE 2
￿
Time-course of binding of [1251)thrombin to ABAE cells .
Nonconfluent cells were incubated with 2.17 fag/ml of [1251]throm-
bin at 37°Cfor varying intervals and theamount of thrombin bound
determined as described in Fig . 1 .
FIGURE 3
￿
Binding of [115 1]thrombin to a specific site on ABAE cells .
[1211] thrombin or [' 15 1] DIP-thrombin, 2 tag/ml, was incubated with
nonconfluent cells (5 x 105/35-mm dish) for 60 min at 37°C as
described in Fig . 1 . After washing and solubilization, the cells were
electrophoresed in an SDS-10% polyacrylamide gel . An autoradi-
ogram was then made of the gel . Lane 1, [12511thrombin and ABAE
cells ; lane 2, ['151]thrombin, ABAE cells, and 100-fold excess of
thrombin; lane 3,
[1251]thrombin, ABAE cells, and 40-fold excess of
DIP-thrombin ; lane 4,
[1251]DIP-thrombin, and ABAE cells; lane 5,
[1251]DIP-thrombin, ABAE cells, and 40-fold excess DIP-thrombin;
lane 6, [12511thrombin .
is necessary for covalent complex formation with ABAE cell
binding sites, active site inhibited thrombin binds reversibly to
these same ABAE cellular sites .
The amount of 77,000-dalton complex formed between
[1251]thrombin and ABAE cells was dependent on whether the
cells were confluent or nonconfluent.To determine the amount
ofthrombin bound in the complex, the gels were sliced and the
amount of radioactive thrombin in the complex measured .
Only a small amount of thrombin formed a complex with
confluent ABAE cells compared to nonconfluent cells (Fig. 4) .
(The graph is a representative result from five separate exper-
iments .) In nonconfluent cultures, thrombin binding saturated
at a concentration of 1 .25-2 .5 tag/ml. Of the total amount of
thrombin specifically bound, 28% was bound in the 77,000-
dalton complex; thus, -70% of thrombin binding appeared to
be noncovalent. As noted, considerably less thrombin bound
to confluent cells ; 37% of the total thrombin bound was in the
77,000-dalton complex. The amount of thrombin bound in the
77,000-dalton complex was 4,600 molecules/cell for confluent
ABAE and 67,000 molecules/cell for nonconfluent ABAE.
When similar binding studies were carried out with confluent
and nonconfluent BCE cells, there was no difference in the
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FIGURE 4
￿
['251]thrombin binding to ABAE cells as a function of the
thrombin concentration .
[1251)thrombin was incubated with sparse
or confluent cells for 30 min at 37°C. After washing, the cells were
solubilized, and subjected to SDS PAGE . After autoradiography to
identify the 77,000-dalton complex, the gel was sliced and the
amount of [125 1]thrombin in the complex determined by gamma
scintillation counting . Calculation of thrombin bound in the 77,000-
dalton complex was corrected for quenching of the radioactivity by
the gel using ['251]standards .
amount of thrombin bound in the 77,000-dalton complex:
90,000 molecules/cell . Thus, in contrast to the ABAE cells,
contact inhibition does not appear to affect the number ofthese
binding sites in BCE cells .
Appearance of Thrombin-binding Sites in
Confluent Cells after Wounding
To obtain information which might clarify the role of the
thrombin binding sites, ABAE cells were grown to confluence,
then a wound was made across the culture plate . After 24 h,
['"I]thrombin was added to the wounded cell cultures and to
confluent control cells. As shown in Fig. 5, release of the cells
from contact-inhibition by wounding resulted in an increase in
77,000-dalton thrombin-cellular complexes. As indicated in
Table 1, there was a 237% increase in the amount of thrombin
bound in the 77,000-dalton complex after wounding . This was
associated with a 2017o decrease in cell number in the plate
containing the wounded monolayer compared to control con-
fluent cultures. No increase in the total amount of noncovalent
thrombin binding occurred in the wounded cultures (Table 1) .
Thus there was a selective increase in those cellular binding
sites with which thrombin forms the covalent 77,000-dalton
complex . In parallel cultures which were wounded similarly to
those in the thrombin binding studies, confluence was reached
3-4 d after injury .
Previous reports have described both noncovalent (1, 25) and
covalent (2, 15, 24) binding ofthrombin to platelets, endothelial
cells, fibroblasts, and carcinoma cells . The significance ofeither
type of binding is unknown. Spontaneous covalent binding of
thrombin to a single type of site resulting in a complex of
68,000-77,000 daltons has been reported with all of these
cells (2, 3, 15, 16, 20, 24) . The role of covalent-thrombin
binding to these diverse types of cells is unknown . Saturation
of covalent surface binding to fibroblasts and endothelial cells
requires -30-60 min (17, 18), while stimulation of platelets
and endothelial cells by thrombin occurs within 1-2 min (4, 6).
It has also been suggested that these binding sites are required
FIGURE 5 Appearance of 77,000-dalton complex between [' 251]-
thrombin and ABAE cells in wounded confluent cultures . Confluent
ABAE cells were wounded with a rubber policeman as described in
Materials and Methods . After 24 h, the cells were incubated with
[' 251]thrombin, 2 ttg/ml, for 1 h, and then washed, solubilized, and
subjected to slab gel electrophoresis and autoradiography as de-
scribed in Fig . 3 . The arrowhead indicates the 77,000-dalton complex .
A, control confluent ABAE cells and
(1211]thrombin . B, confluent
ABAE in which a wound was made 24 h previously, [1251]thrombin
and a 100-fold excess of unlabeled thrombin . C, confluent ABAE
cell in which a wound was made 24 h previously and
[1211]thrombin .
for thrombin-induced mitogenesis of fibroblasts (10) ; however,
there is no direct evidence of this .
In platelets, similar binding sites for thrombin appear only
after secretion .' These binding sites have not been localized in
other types of cells; however, human fibroblasts and bovine
corneal endothelial cells release covalent binding sites for
thrombin into the culture media (3, 23) . Thus, it is possible
that the binding sites are not an integral part of the plasma
membrane. Furthermore, because these sites bind a variety of
proteases, it may be that the binding of thrombin has no
physiological importance, and that their primary function is to
bind another protease. Thus, although the protease inhibitor
a 2-plasmin inhibitor binds plasmin and thrombin covalently,
'T . Maerowitz, J . W . Fenton Il, and M. A. Shuman. Manuscript
submitted for publication.
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673TABLE I
Effect of Culture Wounding on Formation of the 77,000-
dalton Complexbetween
(1251]Thrombin and Confluent ABAE
Cells
Total thrombin in
Total thrombin
￿
77,000-dalton
bound (% in-
￿
complex (% in-
crease)
￿
crease)
ng110 8 cells
￿
ng/10 8 cells
No treatment
￿
3.14
￿
0.35
Wounding of cell
￿
3.61 (15%)
￿
0.83 (237%)
culture
Confluent ABAE cells were wounded with a rubber policeman as described
in Materials and Methods. The cells were incubated for 24 h at 37°C, then
('']thrombin, 1 jug/ml, was added for 1 h, and the cells were washed and
solubilized in SDS buffer. The total amount of
[12511thrombin bound was
measured as indicated in Fig. 1 . The amount of thrombin bound in the 77,000-
dalton complex was measured as indicated in Fig. 4.
binding of thrombin probably has no physiological conse-
quences, whereas binding of plasmin is the major mechanism
for inhibiting fibrinolysis (7, 22).
The importanceofthrombin bindingto fibroblasts is unclear
because these cells have, at most, limited contact with the
coagulation system. This study was undertaken to determine
whether these covalent binding sites are present on endothelial
cells derived from the aorta, a tissue in which there is an
extensive interaction with thrombin when blood coagulation is
activated. In demonstrating the presence of these binding sites,
we discovered that the number of sites is modulated by the
density of cells in culture. This finding is not a result of the
larger size of nonconfluent cells. To account for a 15-fold
greater number of binding sites, the nonconfluent cells would
need to be 3.5-fold longer in diameter, and this is clearly not
the case. Furthermore, one major cause for the overall increase
in thrombin binding is an increase in the number of cellular
sites to which thrombin binds and forms a 77,000-dalton
complex. This increased binding, therefore,cannot be the result
of adherence of thrombin to exposed areas of the culture dish.
That the number of binding sites on confluent and noncon-
fluent BCE cells is the same, indicates a specific effect of cell
density on thrombin binding to aortic endothelium.
Although the function of the covalent binding sites has not
been demonstrated, our finding that additional sites rapidly
appear afterwounding ofABAE cells suggests theirimportance
in the response to vascular injury. Appearance ofthese binding
sites may be a response to a cellular requirement for thrombin
in wound healing. Alternatively, they may serve to inactivate
excess protease formed when the coagulation system is acti-
vated by damaged bloodvessels. Because the active site serine
is required for covalent enzyme binding, uncontrolled prote-
olysis by thrombin may be inhibited in this way. Further
characterization of these binding sites in vascular endothelial
cellswill establish their role in cell function.
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